Caregiver Support Intervention for Caregiver Stress Syndrome
(TACSI Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to assist caregivers of family members with both traumatic brain injury (TBI) and dementia. It tests a new support program called the TBI-AD/ADRD Caregiver Support Intervention (TACSI), which combines emotional and educational assistance to reduce stress and improve caregiving skills. Participants will either try this new program or continue with their usual support services. This trial suits caregivers in the U.S. who are the primary helpers for someone with TBI and dementia and are not currently receiving one-on-one caregiver coaching. As an unphased trial, it offers caregivers a unique opportunity to explore innovative support strategies that could enhance their caregiving experience.
Do I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you are on psychotropic medications like antidepressants, anxiolytics, or anti-psychotics, you must have been on a stable dosage for the past three months to participate.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you are on psychotropic medications (like antidepressants or anti-anxiety drugs), you must have been on a stable dose for the past three months to participate.
What prior data suggests that the TACSI intervention is safe for caregivers?
Research shows that the TBI-AD/ADRD Caregiver Support Intervention (TACSI) helps caregivers manage stress and lighten their load. Studies have examined the practicality and feasibility of this program for those caring for family members with both traumatic brain injury and dementia.
No evidence has emerged of harmful effects or negative experiences from participating in this support program. The program includes coaching and education, which are generally safe methods. As it focuses on support rather than medication or medical procedures, it is considered safe for participants.12345Why are researchers excited about this trial?
Researchers are excited about the TACSI intervention for Caregiver Stress Syndrome because it takes a holistic approach to support caregivers, focusing on their unique challenges and needs. Unlike typical treatments that may only offer basic educational resources or support groups, TACSI provides a structured support system tailored specifically for caregivers of individuals with traumatic brain injury or Alzheimer's disease and related dementias. This intervention aims to reduce stress by combining personalized support with educational resources, potentially leading to better mental health outcomes for caregivers, which is a critical and often overlooked aspect of patient care.
What evidence suggests that the TACSI intervention is effective for caregiver stress syndrome?
Research has shown that the TBI-AD/ADRD Caregiver Support Intervention (TACSI), which participants in this trial may receive, can help reduce stress and burden for caregivers. Studies have found that programs like TACSI, focusing on emotional and educational support, improve caregivers' coping and communication skills. The intervention aims to boost caregivers' confidence and ability to manage caregiving challenges. Early results suggest that caregivers feel less exhausted and more supported. This approach specifically addresses the stress of caring for loved ones with traumatic brain injury and dementia.13567
Are You a Good Fit for This Trial?
This trial is for caregivers over 21 years old in the U.S. who primarily assist a family member with both traumatic brain injury and dementia, are English-speaking, willing to participate, and not receiving similar psychosocial support elsewhere. Caregivers must be stable on any psychotropic medications for three months.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive the TBI-AD/ADRD Caregiver Support Intervention (TACSI) incorporating psychosocial and psychoeducational approaches
Follow-up
Participants are monitored for changes in caregiver primary subjective stress
Extended Follow-up
Participants are further monitored for changes in caregiver primary subjective stress
What Are the Treatments Tested in This Trial?
Interventions
- TBI-AD/ADRD Caregiver Support Intervention (TACSI)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Minnesota
Lead Sponsor
Minneapolis Veterans Affairs Medical Center
Collaborator
Mayo Clinic
Collaborator
United States Department of Defense
Collaborator